MARKET

LEXX

LEXX

Lexaria Bioscience Corp
NASDAQ
10.32
+1.28
+14.16%
After Hours: 10.32 0 0.00% 17:55 08/17 EDT
OPEN
9.31
PREV CLOSE
9.04
HIGH
10.46
LOW
8.74
VOLUME
35.11K
TURNOVER
--
52 WEEK HIGH
23.25
52 WEEK LOW
4.210
MARKET CAP
17.05M
P/E (TTM)
-1.9551
1D
5D
1M
3M
1Y
5Y
1D
Lexaria Bioscience Regains Nasdaq Compliance, Stabilizing Listing
TipRanks · 12h ago
Weekly Report: what happened at LEXX last week (0810-0814)?
Weekly Report · 20h ago
Lexaria Bioscience enters MTA with PegBio
TipRanks · 21h ago
Top Biotech Gainers: HCTI, LEXX, LNSR, JUNS, OMER, AVAH...
NASDAQ · 3d ago
Lexaria Bioscience Stock Rallies Thursday: What Investors Need to Know
Benzinga · 4d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 4d ago
Lexaria Signs PegBio Deal to Test DehydraTECH With GLP-1 Diabetes Drug
TipRanks · 4d ago
Lexaria Bioscience Enters Material Transfer Agreement With Pegbio To Investigate LEXX's DehydraTECH Technology With A Proprietary Pegbio Molecule Under Development For The GLP-1 Industry
Benzinga · 4d ago
More
About LEXX
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company's patented drug delivery formulation and processing platform technology improves the way a wide variety of drugs enter the bloodstream, always through oral delivery. DehydraTECH has also evidenced an ability to deliver some drugs effectively across the blood brain barrier. The Company’s segment includes Intellectual Property, B2B Production, and Research and Development. It is advancing several research and development (R&D) activities in both preclinical and clinical programs. Its focus is the investigation and the incorporation of its DehydraTECH drug delivery technology with glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) to enhance absorption and reduce adverse side effects. The Company operates a licensed in-house research laboratory and holds an intellectual property portfolio with around 48 patents granted and many patents pending worldwide.

Webull offers Lexaria Bioscience Corp stock information, including NASDAQ: LEXX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LEXX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LEXX stock methods without spending real money on the virtual paper trading platform.